StreetInsider.com News Articles

Sterne Kessler and Clarivate partner on AI patent workflow tools

Thu, 15 Oct 2026 11:19:12 -0400

Sterne, Kessler, Goldstein & Fox (Sterne Kessler) and Clarivate Plc (NYSE: CLVT) announced a co-development partnership to build AI-enhanced patent workflow solutions, according to a press release.

The partnership will combine Sterne Kessler's patent practice expertise with Clarivate's IP data and software. The stated goal is to help patent professionals convert technical, legal, and portfolio data into actionable intelligence across the patent lifecycle.

The first phase of the collaboration will focus on enhancing patent drafting workflows within Clarivate's Rowan Patents platform. An initial release is targeted for the first half of 2027.

Simon Webster, President of Intellectual Property at Clarivate, said: "This partnership

Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions

Thu, 15 Oct 2026 11:19:00 -0400

Advancing how teams work more efficiently and make better-informed decisions across the patent lifecycle

WASHINGTON--(BUSINESS WIRE)-- Sterne, Kessler, Goldstein & Fox (Sterne Kessler), a market leading intellectual property (IP) law firm, today announced a co-development partnership with Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, to develop AI-enhanced patent workflow solutions.

This partnership brings together Sterne Kessler’s practitioner-built technology and deep patent practice expertise with Clarivate’s leading IP data and software. Together, the organizations will develop practical, future-ready capabilities that help teams transform technical, legal and portfolio data into actionable intelligence — enabling

Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions

Thu, 15 Oct 2026 11:19:00 -0400

Advancing how teams work more efficiently and make better-informed decisions across the patent lifecycle

Form 8-K/A CLARIVATE PLC For: Oct 06

Tue, 13 Oct 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20261013/27181448.html

Form 4 CLARIVATE PLC For: Oct 06 Filed by: Levy Henry

Thu, 08 Oct 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20261008/27167463.html

Form 8-K CLARIVATE PLC For: Oct 06

Tue, 06 Oct 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20261006/27155920.html

Clarivate completes $600M sale of life sciences unit to Altaris

Tue, 06 Oct 2026 16:15:18 -0400

Clarivate Plc (NYSE: CLVT) has completed the $600 million sale of its Life Sciences & Healthcare segment to Altaris, LLC, a transaction that was first announced on July 6, 2026.

Following the divestiture, Clarivate's portfolio now consists of two segments: Academia & Government, which includes products such as Web of Science, ProQuest, Alma, and Vega; and Intellectual Property, which includes IPOne, Derwent, CompuMark, and IPfolio.

The company said it intends to use the proceeds to reduce debt and strengthen its balance sheet. Clarivate Chief Executive Officer Matti Shem Tov said the transaction "further advances our Value Creation Plan by sharpening our focus,

Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation

Tue, 06 Oct 2026 16:15:00 -0400

Transaction sharpens strategic focus on leading Academia & Government and Intellectual Property segments

Proceeds strengthen balance sheet and enhance financial flexibility

LONDON, Oct. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company"), a leading global provider of transformative intelligence, today

Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation

Tue, 06 Oct 2026 16:15:00 -0400

Transaction sharpens strategic focus on leading Academia & Government and Intellectual Property segments

Proceeds strengthen balance sheet and enhance financial flexibility

LONDON, Oct. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company"), a leading global provider of transformative intelligence, today

Form 4 CLARIVATE PLC For: Sep 30 Filed by: Cornick Kenneth L.

Fri, 02 Oct 2026 17:19:00 -0400

si-local-file:///var/storage/secattach/20261002/27143585.html

Form 4 CLARIVATE PLC For: Sep 30 Filed by: Snyder Andrew Miles

Fri, 02 Oct 2026 17:18:00 -0400

si-local-file:///var/storage/secattach/20261002/27143582.html

Form 4 CLARIVATE PLC For: Sep 30 Filed by: Bomba Jane L Okun

Fri, 02 Oct 2026 17:18:00 -0400

si-local-file:///var/storage/secattach/20261002/27143581.html

Form 8-K CLARIVATE PLC For: Sep 24

Thu, 24 Sep 2026 08:16:00 -0400

si-local-file:///var/storage/secattach/20260924/27099208.html

Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Thu, 24 Sep 2026 08:15:00 -0400

LONDON, Sept. 24, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previously announced cash tender offer (the "Offer") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), to purchase the outstanding 3.875% Senior Secured Notes due 2028 (the "Notes") for aggregate principal amount of up to $75,000,000 (the "Maximum Amount"), upon the terms and subject to the conditions set forth in the

Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Thu, 24 Sep 2026 08:15:00 -0400

Form 8-K CLARIVATE PLC For: Sep 23

Wed, 23 Sep 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260923/27096923.html

Clarivate sets pricing for tender offer on 2028 senior secured notes

Wed, 23 Sep 2026 16:16:06 -0400

Clarivate Plc (NYSE: CLVT), through its wholly-owned subsidiary Clarivate Science Holdings Corporation, announced pricing terms for its cash tender offer to purchase a portion of its outstanding 3.875% Senior Secured Notes due 2028.

The total consideration is $975.15 per $1,000 principal amount of notes validly tendered and accepted. The reference yield was set at 4.864%, determined at 2:00 p.m. New York time on Sept. 23, 2026, based on the bid-side price of the 4.125% U.S. Treasury due June 30, 2028, plus a fixed spread of 50 basis points. Holders whose notes are accepted will also receive accrued and unpaid interest through,

Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Wed, 23 Sep 2026 16:15:00 -0400

LONDON, Sept. 23, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield and Total Consideration (as set forth in the table below) to be paid in connection with its previously announced cash tender offer (the "Offer") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), to purchase the outstanding notes described below, upon the terms and subject to the conditions set forth in the Offer to Purchase

Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Wed, 23 Sep 2026 16:15:00 -0400

Clarivate to Report Third Quarter 2026 Results on November 3, 2026

Tue, 22 Sep 2026 07:30:00 -0400

LONDON, Sept. 22, 2026 /PRNewswire/ -- (PR Newswire) - Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the third quarter 2026 before the market opens on Tuesday, November 3, 2026. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.

Clarivate to Report Third Quarter 2026 Results on November 3, 2026

Tue, 22 Sep 2026 07:30:00 -0400

Clarivate launches tender offer for $75M of its 2028 senior notes

Thu, 17 Sep 2026 08:17:29 -0400

Clarivate Plc (NYSE: CLVT), through its wholly-owned subsidiary Clarivate Science Holdings Corporation, has commenced a cash tender offer to purchase up to $75 million in aggregate principal amount of its 3.875% Senior Secured Notes due July 1, 2028, according to a press release.

The notes have $825 million in aggregate principal amount outstanding. The total consideration per $1,000 principal amount will be determined by a fixed spread of 50 basis points over the yield of the 4.125% U.S. Treasury note due June 30, 2028, as quoted on Bloomberg at 2:00 p.m. New York City time on September 23, 2026, which is

Form 8-K CLARIVATE PLC For: Sep 17

Thu, 17 Sep 2026 08:16:00 -0400

si-local-file:///var/storage/secattach/20260917/27073102.html

Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Thu, 17 Sep 2026 08:15:00 -0400

NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), has commenced a cash tender offer (the "Offer") to purchase the outstanding notes described below, upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 17, 2026 (the "Offer to Purchase").

Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Thu, 17 Sep 2026 08:15:00 -0400